期刊
EUROPEAN JOURNAL OF HEART FAILURE
卷 16, 期 2, 页码 122-132出版社
WILEY
DOI: 10.1002/ejhf.43
关键词
Heart failure; Highlights 2012/13; Pathophysiology; Co-morbidities; Atrial fibrillation; Biomarkers; Pharmacological therapy; Interventional treatment; CRT; Assist devices
Heart failure has become the cardiovascular epidemic of the century. The European Journal of Heart Failure is dedicated to the advancement of knowledge in the field of heart failure management. In 2012 and 2013, several pioneering scientific discoveries and paradigm-shifting clinical trials have been published. In the current paper, we will discuss the most significant novel insights into the pathophysiology, diagnosis, and treatment of heart failure that were published during this period. All relevant research areas are discussed, including pathophysiology, co-morbidities, arrhythmias, biomarkers, clinical trials, and device therapy, including left ventricular assist devices.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据